Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery

I. El-Mokadem (Lead / Corresponding author), J. Fitzpatrick, J. Bondad, P. Rauchhaus, J. Cunningham, N. Pratt, S. Fleming, G. Nabi

    Research output: Contribution to journalArticle

    18 Citations (Scopus)
    136 Downloads (Pure)

    Abstract

    Background:Wider clinical applications of 9p status in clear cell renal cell carcinoma (ccRCC) are limited owing to the lack of validation and consensus for interphase fluorescent in situ hybridisation (I-FISH) scoring technique. The aim of this study was to analytically validate the applicability of I-FISH in assessing 9p deletion in ccRCC and to clinically assess its long-term prognostic impact following surgical excision of ccRCC.Methods:Tissue microarrays were constructed from 108 renal cell carcinoma (RCC) tumour paraffin blocks. Interphase fluorescent in situ hybridisation analysis was undertaken based on preset criteria by two independent observers to assess interobserver variability. 9p status in ccRCC tumours was determined and correlated to clinicopathological variables, recurrence-free survival and disease-specific survival.Results:There were 80 ccRCCs with valid 9p scoring and a median follow-up of 95 months. Kappa statistic for interobserver variability was 0.71 (good agreement). 9p deletion was detected in 44% of ccRCCs. 9p loss was associated with higher stage, larger tumours, necrosis, microvascular and renal vein invasion, and higher SSIGN (stage, size, grade and necrosis) score. Patients with 9p-deleted ccRCC were at a higher risk of recurrence (P=0.008) and RCC-specific mortality (P=0.001). On multivariate analysis, 9p deletion was an independent predictor of recurrence (hazard ratio 4.323; P=0.021) and RCC-specific mortality (hazard ratio 4.603; P=0.007). The predictive accuracy of SSIGN score improved from 87.7% to 93.1% by integrating 9p status to the model (P=0.001).Conclusions:Loss of 9p is associated with aggressive ccRCC and worse prognosis in patients following surgery. Our findings independently confirm the findings of previous reports relying on I-FISH to detect 9p (CDKN2A) deletion.British Journal of Cancer advance online publication, 19 August 2014; doi:10.1038/bjc.2014.420 www.bjcancer.com.
    Original languageEnglish
    Pages (from-to)1381-1390
    Number of pages10
    JournalBritish Journal of Cancer
    Volume111
    Issue number7
    Early online date19 Aug 2014
    DOIs
    Publication statusPublished - 23 Sep 2014

      Fingerprint

    Cite this